C-Reactive Protein and Ischemia in Users and Nonusers of &bgr;-Blockers and StatinsData From the Heart and Soul Study
作者:
Mary Beattie,
Michael Shlipak,
Haiying Liu,
Warren Browner,
Nelson Schiller,
Mary Whooley,
期刊:
Circulation: Journal of the American Heart Association
(OVID Available online 2003)
卷期:
Volume 107,
issue 2
页码: 245-250
ISSN:0009-7322
年代: 2003
出版商: OVID
关键词: coronary disease;ischemia;risk factors;inflammation;epidemiology
数据来源: OVID
摘要:
Background—Elevated levels of C-reactive protein (CRP) are associated with an increased risk of coronary events, but whether inflammation is associated with inducible ischemia in patients with stable coronary disease is unknown.Methods and Results—We recruited patients with known coronary disease from 2 VA Medical Centers and 1 University-based medical center for the Heart and Soul Study. We measured CRP levels in 118 participants who had exercise-induced ischemia and in 111 who did not have inducible ischemia, as determined by stress echocardiography. We used logistic regression to examine the risk of exercise-induced ischemia associated with elevated CRP. We found that 75% (39/52) of participants in the highest CRP category (>0.38 mg/dL) had inducible ischemia, compared with 45% (79/177) in the lower 4 categories combined (adjusted odds ratio 4.2; 95% confidence interval 1.6 to 11;P=0.004). However, this association differed in users and nonusers of &bgr;-blockers and statins. Among 89 participants who did not use &bgr;-blockers, 93% in the highest CRP category had exercise-induced ischemia, compared with 42% in the lower 4 categories (P=0.03). Among 67 participants who did not use statins, 94% in the highest CRP category had exercise-induced ischemia, compared with 44% in the lower 4 categories (P=0.009). We did not observe a significant association between CRP and ischemia among participants who were treated with either of these medications.Conclusion—Elevated CRP levels are associated with inducible ischemia in patients with stable coronary disease, particularly among those not treated with &bgr;-blockers or statins.
点击下载:
PDF
(167KB)
返 回